BBP ETF (Virtus LifeSci Biotech Products ETF) is managed by Virtus Investment Partners with $50.5M in net assets. BBP expense ratio is 0.79%, holding 65 positions across sectors including Health Care, Unknown, Other. Inception date: 2014-12-16.

BBP performance shows a YTD return of 6.79%. The 1-year return is 36.82% and the 5-year return is 9.19%.

BBP top holdings include Immunitybio Inc (4.0%), Mirum Pharmaceuticals Inc (2.4%), Moderna therapeutics (2.1%), Dynavax Technologi Com New (2.1%), Amicus Therapeutics Inc (2.0%). View all BBP holdings, sector breakdown, or dividend history.

BBP can be compared against other funds using the overlap calculator or side-by-side comparison tool. BBP alternatives are available via the screener, along with tax-loss harvesting opportunities.